Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 971.00
+14.80 (1.55%)
May 22, 2025, 3:29 PM IST
Windlas Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
| Revenue | 7,285 | 6,310 | 5,131 | 4,659 | 4,276 | 3,289 | Upgrade
|
| Revenue Growth (YoY) | 21.33% | 22.97% | 10.12% | 8.96% | 30.03% | 7.03% | Upgrade
|
| Cost of Revenue | 4,581 | 4,004 | 3,296 | 3,079 | 2,791 | 2,137 | Upgrade
|
| Gross Profit | 2,704 | 2,305 | 1,835 | 1,581 | 1,485 | 1,152 | Upgrade
|
| Selling, General & Admin | 1,192 | 927.74 | 736.88 | 656.86 | 596.43 | 445.06 | Upgrade
|
| Other Operating Expenses | 606.8 | 595.94 | 495.85 | 399.53 | 324.41 | 291.85 | Upgrade
|
| Operating Expenses | 2,030 | 1,658 | 1,356 | 1,178 | 1,050 | 829.84 | Upgrade
|
| Operating Income | 673.78 | 647.28 | 478.7 | 402.76 | 434.14 | 322.11 | Upgrade
|
| Interest Expense | -33.32 | -11.05 | -7.88 | -14.17 | -12.9 | -25.26 | Upgrade
|
| Interest & Investment Income | 19.69 | 19.69 | 34.9 | 42.85 | 19.21 | 10.79 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -1.73 | -74.66 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.23 | 3.23 | 3.82 | 4.77 | 1.03 | -0.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 44.02 | 3.49 | 4.35 | 0.77 | 1.98 | 0.28 | Upgrade
|
| EBT Excluding Unusual Items | 707.4 | 662.64 | 513.89 | 436.98 | 441.73 | 232.97 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -272.64 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 108.21 | 108.21 | 47.82 | 18.57 | 62.22 | 13.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 0.06 | 8.76 | 0.1 | 0.09 | -0.08 | Upgrade
|
| Asset Writedown | - | - | -0.08 | - | -14 | -0.01 | Upgrade
|
| Pretax Income | 815.67 | 770.91 | 570.39 | 455.65 | 217.4 | 246.68 | Upgrade
|
| Income Tax Expense | 198.61 | 189.04 | 144.13 | 74.76 | 61.7 | 84.55 | Upgrade
|
| Earnings From Continuing Operations | 617.06 | 581.87 | 426.26 | 380.89 | 155.7 | 162.13 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 2.62 | - | Upgrade
|
| Net Income | 617.06 | 581.87 | 426.26 | 380.89 | 158.32 | 162.13 | Upgrade
|
| Net Income to Common | 617.06 | 581.87 | 426.26 | 380.89 | 158.32 | 162.13 | Upgrade
|
| Net Income Growth | 17.23% | 36.51% | 11.91% | 140.58% | -2.35% | -74.60% | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 22 | 20 | 18 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 21 | 22 | 20 | 18 | 18 | Upgrade
|
| Shares Change (YoY) | 0.73% | -3.53% | 5.56% | 12.58% | - | 7.40% | Upgrade
|
| EPS (Basic) | 29.58 | 27.97 | 19.70 | 18.58 | 8.70 | 8.90 | Upgrade
|
| EPS (Diluted) | 29.28 | 27.88 | 19.70 | 18.58 | 8.70 | 8.90 | Upgrade
|
| EPS Growth | 16.40% | 41.52% | 6.03% | 113.68% | -2.30% | -76.36% | Upgrade
|
| Free Cash Flow | - | 712.76 | -99.25 | -56.74 | 56.07 | 96.96 | Upgrade
|
| Free Cash Flow Per Share | - | 34.15 | -4.59 | -2.77 | 3.08 | 5.33 | Upgrade
|
| Dividend Per Share | 5.500 | 5.500 | 4.000 | 3.500 | - | - | Upgrade
|
| Dividend Growth | - | 37.50% | 14.29% | - | - | - | Upgrade
|
| Gross Margin | 37.12% | 36.54% | 35.77% | 33.92% | 34.72% | 35.03% | Upgrade
|
| Operating Margin | 9.25% | 10.26% | 9.33% | 8.64% | 10.15% | 9.79% | Upgrade
|
| Profit Margin | 8.47% | 9.22% | 8.31% | 8.18% | 3.70% | 4.93% | Upgrade
|
| Free Cash Flow Margin | - | 11.30% | -1.93% | -1.22% | 1.31% | 2.95% | Upgrade
|
| EBITDA | 793.58 | 762.1 | 586.88 | 515.48 | 552.26 | 405.68 | Upgrade
|
| EBITDA Margin | 10.89% | 12.08% | 11.44% | 11.06% | 12.91% | 12.34% | Upgrade
|
| D&A For EBITDA | 119.8 | 114.82 | 108.18 | 112.72 | 118.12 | 83.57 | Upgrade
|
| EBIT | 673.78 | 647.28 | 478.7 | 402.76 | 434.14 | 322.11 | Upgrade
|
| EBIT Margin | 9.25% | 10.26% | 9.33% | 8.64% | 10.15% | 9.79% | Upgrade
|
| Effective Tax Rate | 24.35% | 24.52% | 25.27% | 16.41% | 28.38% | 34.27% | Upgrade
|
| Revenue as Reported | 7,460 | 6,444 | 5,230 | 4,726 | 4,307 | 3,313 | Upgrade
|
| Advertising Expenses | - | 48.32 | 29.75 | 18.4 | 12.79 | 8.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.